← Back to Search

Group-Based Prenatal Care for Preventing Premature Birth

N/A
Recruiting
Led By Britni L Ayers, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pregnant at 12-14 weeks gestation
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all maternal and infant health records will be collected at six weeks postpartum
Awards & highlights

Study Summary

This trial will measure if group-based prenatal care with care navigation can improve health outcomes for US Pacific Islanders, reducing infant & maternal mortality & morbidity.

Who is the study for?
This trial is for pregnant Marshallese women, aged 18 or older, who are in their first trimester (12-14 weeks gestation). It's not open to those who used fertility treatments, have a high-risk pregnancy requiring special care, are expecting multiple babies, or take medications that affect fetal growth.Check my eligibility
What is being tested?
The study tests 'Centering Pregnancy with Care Navigation' against standard prenatal care. It aims to see if this group-based program can improve attendance at care appointments and outcomes like preterm birth rates and infant weight.See study design
What are the potential side effects?
Since the intervention involves supportive group prenatal programs rather than medication, there aren't typical side effects. However, participants may experience varying levels of emotional comfort or stress due to the social nature of the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently 12-14 weeks pregnant.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all maternal and infant health records will be collected at six weeks postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and all maternal and infant health records will be collected at six weeks postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with a caesarean delivery.
Number of participants with infants that are preterm.
Number of participants with infants with low birthweight
Secondary outcome measures
The number of social services participants are enrolled in at the end of the intervention.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Centering Pregnancy with Care Navigation for pregnant Marshallese womenExperimental Treatment1 Intervention
Forty pregnant Marshallese women will be enrolled in the group prenatal intervention, Centering Pregnancy, with care navigation to determine the feasibility of the intervention and the preliminary effectiveness to improve maternal and infant health care outcomes.
Group II: Pregnant Marshallese women enrolled in standard prenatal careActive Control1 Intervention
We will use a 1:1 propensity score matching with pregnant Marshallese women who completed standard prenatal care to compare their maternal and infant health care outcomes with those participants enrolled in the intervention.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
485 Previous Clinical Trials
149,833 Total Patients Enrolled
1 Trials studying Premature Birth
30 Patients Enrolled for Premature Birth
Britni L Ayers, PhDPrincipal InvestigatorUniversity of Arkansas for Medical Sciences Northwest

Media Library

Centering Pregnancy with Care Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05645549 — N/A
Premature Birth Research Study Groups: Pregnant Marshallese women enrolled in standard prenatal care, Centering Pregnancy with Care Navigation for pregnant Marshallese women
Premature Birth Clinical Trial 2023: Centering Pregnancy with Care Navigation Highlights & Side Effects. Trial Name: NCT05645549 — N/A
Centering Pregnancy with Care Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05645549 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this experiment still available to those seeking medical assistance?

"According to clinicaltrials.gov, the current recruitment for this trial has been discontinued since December 1st 2022; after first being posted on March 5th 2023. However, there are still 263 other studies actively seeking participants at present."

Answered by AI
~12 spots leftby Aug 2024